Lynch Thomas G 4
4 · Evofem Biosciences, Inc. · Filed Aug 15, 2018
Insider Transaction Report
Form 4
Lynch Thomas G
Director
Transactions
- Purchase
Common Stock
2018-08-14$2.10/sh+31,071$65,249→ 106,071 total - Purchase
Common Stock
2018-08-15$2.33/sh+68,929$160,605→ 175,000 total
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.098 to $2.10, inclusive. The reporting person undertakes to provide to Evofem Biosciences, Inc. (Evofem), any security holder of Evofem, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4.
- [F2]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.25 to $2.39, inclusive. The reporting person undertakes to provide to Evofem Biosciences, Inc. (Evofem), any security holder of Evofem, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (2) to this Form 4.